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Following a hospital outbreak of vancomycin-resistant E. faecium vanB involving 44 39 
patients, we initiated screening of contacts (roommates or patients hospitalized in an 40 
epidemic ward) who had not been screened before discharge. Between July and 41 
December 2011, a mobile team of 5 nurses performed home screening. Of 256 eligible 42 
contacts, 223 (87%) were screened. Median time between discharge from the epidemic 43 
ward and screening was 163 days (range 0-361). No contact patient was found to be 44 
positive. We showed the feasibility of home screening by visiting nurses and concluded 45 
that preemptive isolation is not justified for contacts readmitted 3 months after 46 
discharge. 47 
 48 
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Vancomycin-resistant enterococcus (VRE) is a significant healthcare associated 58 
pathogen. VRE has become endemic in many countries and repeatedly causes 59 
nosocomial outbreaks. Some epidemic clones are highly transmissible and able to 60 
persist up to 16 weeks on inert surfaces 1-3. Measures to limit the spread of this 61 
bacterium, notably cohorting of VRE carriers and extensive screening and cohorting of 62 
contact patients, appears essential to control a VRE outbreak 4-7. 63 
Contact patients discharged before exclusion of VRE carriage can be the source of 64 
reintroduction of VRE into the hospital upon readmission. Despite this risk, there is no 65 
recommendation about the optimal management of contact patients. At Lausanne 66 
University hospital, readmitted contact patients are quarantined in contact isolation until 67 
3 consecutive rectal swabs are negative.  68 
 69 
After a vanB Enterococcus faecium outbreak, we evaluated the VRE carriage of 70 
discharged contact patients through VRE home screenings by visiting nurses. A VRE 71 
contact was defined as a patient who had shared the room of a patient carrying VRE or 72 
who had stayed in a ward with > 2 VRE cases within previous month. Contact patients 73 
were identified through administrative databases. VRE colonization was ruled out when 74 
3 rectal swabs taken at least a week apart were negative 4. Contact patients who had 75 
left the hospital before performing the 3 swabs were introduced into an alert system and 76 
followed-up: those who lived in Lausanne and suburbs were first informed by letter and 77 
then contacted by phone in order to obtain their consent for VRE screening at home. A 78 
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mobile team of five nurses visited the consenting patients and completed the screening 79 
protocol.  80 
Rectal swabs were inoculated into an enrichment broth containing vancomycin and 81 
incubated at 37°C for 24h. The broth was inoculated onto a selective chromogenic plate 82 
(ChromID VRE, Biomérieux) and incubated at 37°C for 48h. 83 
The cost of the ambulatory screening campaign were computed by summing up the 84 
nursing wage (€48.74 per hour), the travel cost (€0.67 per Km) and the laboratory cost 85 
of swab tests (€100.- if positive, €40.- if negative). The isolation cost was estimated by 86 
summing up the costs of contact precautions material, additional nurse and physician 87 
time, cleaning of room 8 and extra for single room (€100.- per day). 88 
In our hospital, the prevalence of vancomycin-resistance in enterococci isolated from 89 
clinical samples is below 1%. During the course of the outbreak, we identified 44 VRE-90 
positive patients, of whom 5 were identified by clinical samples and 39 were contact 91 
patients detected by screening during their hospital stay 9. Within the 453 remaining 92 
contact patients, 115 (25%) had three negative screenings before discharge, 28 (6%) 93 
had died, and 54 (12%) lived outside the investigation area. Thus, 256 contact patients 94 
were eligible for ambulatory screening, of whom 33 (13%) were excluded: 27 could not 95 
be reached and 6 refused to participate. Of the 223 included patients, 203 (91%) 96 
completed the screening protocol (3 swabs), 16 (7%) had 2 swabs and 4 (2%) one 97 
swab. Characteristics of the patients are presented in Table 1. All included patients 98 
were ambulatory and living independently. The median length of stay in an epidemic 99 
ward was 7 days (range 1-119) and the median time elapsed between discharge and 100 
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the first VRE screening was 163 days (range 0-361). The majority of patients had the 3 101 
successive screenings done at home (170 of 203 patients, 84%). 102 
None of the included patients were colonized by VRE. The mobile team needed 554 103 
hours (€27’000.-) and 2'396 km (€1’600.-), and performed 645 screening swabs 104 
(€25’800.-). Thus, the total cost of the home screening process was €54’400.-. Twenty-105 
five of the 223 contact patients included (11%) were readmitted within 3 months, 106 
totalizing 214 isolation days at a cost of €21’400.-  107 
 108 
To our knowledge, this is the first report of a home screening campaign of VRE 109 
contacts. Patient acceptance was good. We did not identify any VRE carriage. 110 
Hypotheses to explain this result could be and the relatively short length of stay on an 111 
epidemic ward (median 7 days) and the delay between discharge and VRE screening 112 
(median of 163 days), whereas the median time of VRE carriage during a large 113 
outbreak was 42 days 10. A screening performed faster after discharge and longer 114 
hospitalizations could have led to higher rate of VRE-positive contacts. Pearman et al. 115 
described the screening of 1’977 ward contacts after discharge from hospital 11. 116 
Screening swabs were obtained in outpatient clinic, upon readmission or upon 117 
admission to another hospital. Screening lasted for 7 months and detected 54 cases of 118 
VRE carriage (acquisition rate: 2.73%), with a declining yield over time. 119 
Screening contact patients at home by a mobile team managed by the hospital, 120 
guarantees an exhaustive monitoring and centralization of results. The cost generated 121 
by the procedure and the time required for the organization of the mobile team are 122 
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limiting factors. However, the cost is partially offset as screened contact patients will not 123 
be the source of new transmissions in case of readmission, and contact isolation days 124 
are avoided.  125 
 126 
In conclusion, we showed the feasibility of home screening by visiting nurses. It could 127 
be useful in case of an outbreak of a virulent pathogen that requires strict infection 128 
control measures in contact patients. Based on our experience and the literature 10,11, 129 
we now recommend in our hospital isolation and screening of VRE contact patients if 130 
readmitted within 3 months after discharge, and screening without isolation beyond that 131 
time.  132 
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Table 1. Characteristics of VRE contact patients screened at home (n=223) 167 
 168 
 169 
Characteristic  
Age (years, range)   64 
Male gender (%) 104 (46.6) 
Hospitalization in surgical ward (%) 166 (74.4) 
Hospitalization in medical ward (%) 57 (25.6) 
Median length of stay (days; range) 7 (1-119) 
Median length of stay on an epidemic ward (days; range) 6 (1-60) 
Median time elapsed between discharge and VRE 
screening (days; range) 
163 (0-361) 
Readmission within 3 months (%) 25 (11.2) 
 170 
